Advertisement

Prevention of Infection in Kidney Patients

  • Sophie Collier
  • Susan Hopkins
Chapter

Abstract

Renal patients are particularly vulnerable to infection. They are relatively immunocompromised and undergo numerous invasive procedures, which put them at risk of infection. They receive multiple antibiotics, which select out resistant organisms and attend healthcare environments on a frequent basis, allowing ample opportunity for multidrug-resistant organisms to spread. Many patients are on immunosuppressive agents to treat their underlying renal disease or following a kidney transplant.

Keywords

Peritoneal Dialysis Hand Hygiene Peritoneal Dialysis Patient Personal Protective Equipment Renal Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58(4):1758–64.PubMedCrossRefGoogle Scholar
  2. 2.
    WHO guidelines on hand hygiene in health care. 2009. http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf.
  3. 3.
    Shahid NS, et al. Hand washing with soap reduces diarrhoea and spread of bacterial pathogens in a Bangladesh village. J Diarrhoeal Dis Res. 1996;14(2):85–9.PubMedGoogle Scholar
  4. 4.
    Luby SP, et al. Effect of intensive handwashing promotion on childhood diarrhea in high-risk communities in Pakistan: a randomized controlled trial. JAMA. 2004;291(21):2547–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Cardoso CL, et al. Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control. 1999;27(4):327–31.PubMedCrossRefGoogle Scholar
  6. 6.
    Gordin FM, et al. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol. 2005;26(7):650–3.PubMedCrossRefGoogle Scholar
  7. 7.
    Pratt RJ, et al. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect. 2001;47(Suppl):S3–82.PubMedCrossRefGoogle Scholar
  8. 8.
    Public Health Laboratory Service AIDS and STD Centre. Occupational transmission of HIV. London; 1999.Google Scholar
  9. 9.
    Haley RW, et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control. 1985;13(3):97–108.PubMedCrossRefGoogle Scholar
  10. 10.
    Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–31.PubMedGoogle Scholar
  11. 11.
    Engemann JJ, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol. 2005;26(6): 534–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Simor AE. Staphylococcal decolonisation: an effective strategy for prevention of infection? Lancet Infect Dis. 2011;11(12):952–62.PubMedCrossRefGoogle Scholar
  13. 13.
    Tacconelli E, et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37(12):1629–38.PubMedCrossRefGoogle Scholar
  14. 14.
    Fluck R, Kumwenda M. Renal association guidelines – vascular access for haemodialysis; 2011. www.renal.org/guidelines/modules/vascular-access-for-haemodialysis.
  15. 15.
    Woodrow G, Davies S. Clinical practice guidelines: peritoneal dialysis. UK Renal Association; 2010. www.renal.org/guidelines/modules/peritoneal-dialysis-in-ckd.
  16. 16.
    Clostridium difficile infection: how to deal with the problem. 2008. www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1232006607827.
  17. 17.
    Cornely OA, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012;12(4):281–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Louie TJ, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–31.PubMedCrossRefGoogle Scholar
  19. 19.
    Klevens RM, et al. Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial. 2008;21(1):24–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Hannah EL, et al. Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol. 2002;23(9):538–41.PubMedCrossRefGoogle Scholar
  21. 21.
    O’Grady N, Alexander M, Burns L, Dellinger E, Garland J, O’Heard S, Lipsett P, Masur H, Mermel L, Pearson M, Raad I, Randolph A, Rupp M, Saint S. The Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the preventions of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–93.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Chatzinikolaou I, et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med. 2003;115(5):352–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Chaiyakunapruk N, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136(11):792–801.PubMedCrossRefGoogle Scholar
  24. 24.
    NKF KDOQI Guidelines: clinical practice guidelines for vascular access. 2006. www.kidney.org/PROFESSIONALS/kdoqi/guideline...PD.../index.htm.
  25. 25.
    Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2011;79(6):587–98.PubMedCrossRefGoogle Scholar
  26. 26.
    Lok CE, et al. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol. 2003;14(1):169–79.PubMedCrossRefGoogle Scholar
  27. 27.
    Yahav D, et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47(1):83–93.PubMedCrossRefGoogle Scholar
  28. 28.
    Piraino B, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011;31(6): 614–30.PubMedCrossRefGoogle Scholar
  29. 29.
    Figueiredo A, et al. Clinical practice guidelines for peritoneal access. Perit Dial Int. 2010;30(4):424–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Dombros N, et al. European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. Nephrol Dial Transplant. 2005;20 Suppl 9:ix8–12.PubMedGoogle Scholar
  31. 31.
    Strippoli GF, et al. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol. 2004;15(10):2735–46.PubMedCrossRefGoogle Scholar
  32. 32.
    Nessim SJ, Bargman JM, Jassal SV. Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis. Nephrol Dial Transplant. 2010;25(7):2310–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Bernardini J, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol. 2005;16(2):539–45.PubMedCrossRefGoogle Scholar
  34. 34.
    Churchill DN, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19(3):214–34.PubMedGoogle Scholar
  35. 35.
    Englesbe MJ, et al. Single center review of femoral arteriovenous grafts for hemodialysis. World J Surg. 2006;30(2):171–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Zibari GB, et al. Preoperative vancomycin prophylaxis decreases incidence of postoperative hemodialysis vascular access infections. Am J Kidney Dis. 1997;30(3):343–8.PubMedCrossRefGoogle Scholar
  37. 37.
    van Loon MM, et al. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant. 2010;25(1):225–30.PubMedCrossRefGoogle Scholar
  38. 38.
    Nesrallah GE, et al. Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis. Clin J Am Soc Nephrol. 2010;5(6):1047–53.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Report of the Rosenheim Advisory Group. Hepatitis and the treatment of chronic renal failure. London: Department of Health and Social Security; 1972.Google Scholar
  40. 40.
    Department of Health (UK). Good practice guidelines for renal dialysis/transplantation units: prevention and control of blood-borne virus infection. London: Department of Health (UK); 2002.Google Scholar
  41. 41.
    Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl. 2008;73(109):S1–99.Google Scholar
  42. 42.
    Canadian Society of Nephrology guidelines for prevention of blood borne infections in dialysis units. CANNT J. 2007. www.thefreelibrary.com.
  43. 43.
    Jadoul M, Cornu C, van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int. 1998;53(4): 1022–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Department of Health (UK). Good practice guidelines for renal dialysis/transplantation units, prevention & control of blood-borne virus infection. Addendum guidelines for dialysis away from base. London: Department of Health (UK); 2010.Google Scholar
  45. 45.
    Department of Health. Immunisation against infectious disease – ‘The Green Book’ – 2006 updated edition. 2nd ed. London: Department of Health (UK); 2007.Google Scholar
  46. 46.
    NICE guideline: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2011. www.nice.org.uk/nicemedia/live/13422/53642/53642.pdf.

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of MicrobiologyRoyal Free London NHS Foundation Trust, Royal Free HospitalLondonUK
  2. 2.Department of Infectious Diseases and Clinical MicrobiologyRoyal Free London NHS Foundation TrustLondonUK

Personalised recommendations